Cryopreservation – News and Features

A repurposed anti-cancer drug, Cilengitide, was found to reduce kidney scarring and slow disease progression in preclinical models, suggesting a possible precision medicine approach for high-risk patients.

Explore how proteomics, AI and microsampling are advancing biomarker discovery. Learn how these innovations are shaping the future of precision medicine.

The limitations of traditional cryopreservation are becoming increasingly apparent. In this interview, Alastair Carrington, CEO of Atelerix, explores how hypothermic preservation technology is transforming biopreservation.

The brain's cholesterol regulation and metabolism mechanisms may make some neurons more vulnerable to damage in the early stages of Alzheimer's disease.

A cohort study of 85,000 adults found that engaging in light and moderate physical activity daily lowers cancer risk. Participants who replaced sedentary time with physical activity had a reduced risk of developing cancer.

With 23andMe filing for bankruptcy, customers worry about their genetic data. Learn what experts say about privacy and data protection.

In this article, Cristiana Bercea discusses how large, automated storage solutions are helping companies to save time, unlock greater efficiency and better meet sustainability goals – without increasing risk.

Endometrial organoids, 3D cell cultures mimicking the endometrium, offer new opportunities in endometriosis research. These models are key in studying drug targets, fertility issues and gynecological cancers.

We spoke with Dr. Michael Gonzales to learn more about the UKB-PPP and its goals, the technical hurdles of large-scale proteomics and how Olink technology is helping to overcome them.

Researchers have revealed that vascular dysfunction can contribute to neurodegenerative diseases including Alzheimer's and ALS.